A rapid and simple Sep Pak method for purification of radioiodinated IQNP, a high affinity ligand for the muscarinic receptor

Nuclear Medicine and Biology

Volumn 26, Issue 7, 1999, Pages 859-863

  McPherson, D W ^a   Knapp Jr , F F ^a  

^a Life Sci Div Oak Ridge Natl L   (United States)

Author keywords

IQNP; Muscarinic receptor; Sep Pak purification

Indexed keywords

3 QUINUCLIDINYL 4 IODOBENZILATE; IODINE 131; IODINE DERIVATIVE; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NONHUMAN; RADIOCHEMISTRY; RAT; RECEPTOR AFFINITY; STEREOISOMERISM;

ANIMALS; BRAIN; FEMALE; IODINE RADIOISOTOPES; LIGANDS; MUSCARINIC ANTAGONISTS; QUINUCLIDINES; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; RECEPTORS, MUSCARINIC; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 0032711222     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00050-5     Document Type: Article

References (14)

1. 1 acetylcholine receptors in brain. Determination of metabolites using HPLC . Nucl. Med. Biol. 25:1998;209-214.
2. Bergstrom K.A., Halldin C., Savonen A., Okubo Y., Hiltunen J., Swahn C.G., McPherson D., Knapp F.F. Jr, Larsson S., Schnell P.O., Farde L. Iodine-123 labelled Z-(R,R)-IQNP A potential radioligand for visualization of m2 muscarinic acetylcholine receptors in brain with SPECT . Eur. J. Nucl. Med. 25:1998;843.
3. 1 cells. Mol. Pharmacol. 35:1989;469-476.
4. Flynn D.D., Ferrari-DiLeo G., Mash D.C., Levey A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem. 64:1995;1888-1891.
5. Jenni-Eiermann S., Von Hahn H.P., Honegger G.C., Ulrich J. Studies on neurotransmitter binding in senile dementia. Gerontology. 30:1984;350-358.
6. Kung M.-I., Liu B.-L., Yang Y.-Y., Billings J.J., Kung H.F. A kit formulation for preparation of iodine-123-IBZM A new CNS D-2 dopamine receptor imaging agent . J. Nucl. Med. 32:1991;339-342.
7. Levey A.I. Muscarinic acetylcholine receptor expression in memory circuits Implications for treatment of Alzheimer disease . Proc. Natl. Acad. Sci. USA. 93:1996;13541-13546.
8. McPherson D.W., Knapp F.F. Jr. Structure elucidation via stereoselective synthesis of the acetate center of labeled 1-azabicyclo[2.2.2]oct-3-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate (IQNP). A high affinity muscarinic imaging agent for SPECT. J. Org. Chem. 61:1996;8335-8337.
9. McPherson D.W., Lambert C.R., Jahn K., Sood V., McRee R.C., Zeeberg B.R., Reba R.C., Knapp F.F. Jr. Resolution, in vitro and initial in vivo evaluation of isomers of iodine-125 labeled 1-azabicyclo[2.2.2]oct-3-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate (IQNP). J. Med. Chem. 38:1995;3908-3917.
10. McPherson D.W., Luo H., Beets A.L., Knapp F.F. Jr. A novel in vivo method for the determination of muscarinic ligand subtype selectivity. Eur. J. Nucl. Med. 25:1998;843.
11. Nordberg A., Alaguzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain Changes with aging and dementia . J. Neurosci. Res. 31:1992;103-111.
12. Rayeq M.R., Boulay S.F., Sood V.K., McPherson D.W., Knapp F.F. Jr, Zeeberg B.R., Reba R.C. In vivo autoradiographic evaluation of isomers of 1-125-labeled 1-azabicyclo[2.2.2]oct-3-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate (IQNP). A high affinity ligand for the muscarinic receptor. Recept. Signal Transduct. 6:1996;13-34.
13. Wang T.S.T., Malaspina D., Van Heertum R.L. A simple method of preparation for [I-123]-(S)-(-)-IBZM. Appl. Radiat. Isotopes. 49:1998;369-372.
14. 2 muscarinic subtype selectivity for QNB. Recept. Signal Transduct. 7:1997;45-54.